The ET-axis evidently contributes to PCa pathophysiology: in prostate carcinoma, ET-1 levels are systemically increased and silencing ET-1 by RNAi significantly suppresses the progression and invasion of prostate cancer cells. Here, EDN1 is linked to prostate cancer.